Turn Therapeutics Cash Flow Statement (2024-2026) | TTRX

1Y3Y5Y7Y10YAll
Download Data
Cash Flow Statement Sep2024 Dec2024 Mar2025 Sep2025 Dec2025 Mar2026
Operating Activities
Net Income (Quarter) -1.03M-0.47M-0.57M-7.58M-2.93M-3.15M
Share-based Compensation (Quarter) 0.04M0.08M0.31M0.26M1.20M
Asset Writedowns and Impairment (Quarter) 0.48M
Cash from Operations (Quarter) -0.43M-0.30M-1.21M-1.60M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter) 0.01M0.01M
Change in Working Capital
Change in Accured Expenses (Quarter) 0.05M-0.02M0.66M-0.61M
Investing Activities
Cash from Investing Activities (Quarter) -0.01M-0.03M-0.01M
Financing Activities
Change in Capital Stock
Shares Issued (Quarter) 1.58M3.00M1.94M1.63M
Net Equity Issued and Repurchased (Quarter) 75.00M0.30M3.18M
Misc.
Cash from Financing Activities (Quarter) 0.52M1.00M3.18M7.79M
Change in Cash (Quarter) 0.08M0.70M1.97M6.14M
Free Cash Flow (Quarter) -0.43M-0.30M-1.21M-1.60M
Net Cash Flow (Quarter) 0.08M0.70M1.94M6.17M